BRIEF—Dutch collaboration to create large exome dataset for analysis

Rare disease specialist GeneDx, part of Nasdaq-listed OPKO Health, has entered into a research collaboration with the Radboud University Medical Center, Netherlands.

The two organizations are seeking to identify novel genes and pathways implicated in the pathology of human genetic diseases, and to improve diagnostic approaches.

The deal will see GeneDx add 3,000 cases to its study cohort from Radboud, creating the largest combined dataset of neurodevelopmental exomes for analysis.

Chief innovation officer at GeneDx Kyle Retterer said: "The shared combination of our data summaries and analytical tools to conduct meta-analyses of GeneDx and Radboud datasets will help us better understand the genetic basis of neurological health and disease."